Demahy v. Actavis Inc.

Decision Date22 August 2011
Docket NumberNo. 08–31204.,08–31204.
Citation650 F.3d 1045
PartiesJulie DEMAHY, Plaintiff–Appelleev.ACTAVIS, INC., Individually and as Successor in Interest of Purepac Pharmaceutical Company, Defendant–Appellant.
CourtU.S. Court of Appeals — Fifth Circuit

OPINION TEXT STARTS HEREKristine K. Sims, Brian Leonard Glorioso, Richard Alvin Tonry, II, Tonry, Brinson & Glorioso, L.L.C., Slidell, LA, Louis M. Bograd (argued), Center for Constitutional Litigation, P.C., Washington, DC, for PlaintiffAppellee.Richard A. Dean (argued), Irene Childress Keyse–Walker, Kristen Lepke Mayer, Tucker Ellis & West, L.L.P., Cleveland, OH, Elizabeth Haecker Ryan, Lemle & Kelleher, L.L.P., New Orleans, LA, for DefendantAppellant.Joseph Paul Thomas, Linda E. Maichl, Ulmer & Bernel, L.L.P., Cincinnati, OH, for Amicus Curiae.

Appeal from the United States District Court for the Eastern District of Louisiana.Before KING, HIGGINBOTHAM, and CLEMENT, Circuit Judges.

ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES

PER CURIAM:

The Supreme Court having reversed the judgment of this Court and remanded this action for further proceedings in light of its opinion in PLIVA, Inc. v. Mensing, ––– U.S. ––––, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011), we vacate the district court's order denying in part the motion to dismiss and remand for the entry of judgment in favor of the defendant-appellant, Actavis, Inc.

VACATED and REMANDED

To continue reading

Request your trial
12 cases
  • Demahy v. Schwarz Pharma, Inc.
    • United States
    • U.S. Court of Appeals — Fifth Circuit
    • 25 Octubre 2012
    ...order denying in part the motion to dismiss, and it remanded for the entry of judgment in favor of Actavis. Demahy v. Actavis, Inc., 650 F.3d 1045, 1046 (5th Cir.2011). Accordingly, the district court granted “judgment in favor of Defendant, Actavis, Inc. and against Plaintiff, Julie Demahy......
  • Morris v. Pliva, Inc.
    • United States
    • U.S. Court of Appeals — Fifth Circuit
    • 14 Febrero 2013
    ...which held state law claims against generic manufacturers of Reglan preempted by FDA regulations. See also Demahy v. Actavis, Inc., 650 F.3d 1045 (5th Cir.2011) (per curiam). Accordingly, we AFFIRM the dismissal of this suit.BACKGROUND Penny Morris took metoclopramide from early 2006 to Jul......
  • Morris v. PLIVA, Inc.
    • United States
    • U.S. Court of Appeals — Fifth Circuit
    • 14 Abril 2013
    ...which held state law claims against generic manufacturers of Reglan preempted by FDA regulations. See also Demahy v. Actavis, Inc., 650 F.3d 1045 (5th Cir. 2011) (per curiam). Accordingly, we AFFIRM the dismissal of this suit.BACKGROUND Penny Morris took metoclopramide from early 2006 to Ju......
  • Purvis v. Teva Pharm., USA, Inc.
    • United States
    • U.S. District Court — Middle District of Louisiana
    • 30 Octubre 2012
    ...Administratively Close this case (doc. 25) until such time as the Supreme Court ruled on the motion for rehearing in Demahy v. Actavis, Inc., 650 F.3d 1045 (5th Cir.2011). On August 22, 2011 the Supreme Court denied Plaintiff's Motion for Rehearing in Actavis.Id. Subsequently, the prior ord......
  • Request a trial to view additional results
1 firm's commentaries
  • Supreme Court Decision Alert - June 24, 2013
    • United States
    • Mondaq United States
    • 26 Junio 2013
    ...2012); Mensing v. Wyeth, Inc., 658 F.3d 867 (8th Cir. 2011); Smith v. Wyeth, Inc., 657 F.3d 420 (6th Cir. 2011); Demahy v. Actavis, Inc., 650 F.3d 1045 (5th Cir. Bartlett is significant for the business community because it clarifies and reaffirms Mensing's holding that claims against a gen......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT